Physician profile
Sunilkumar Rao
NPI 1508875386
$2,340.16
in general payments reported to CMS, 2019-2025
17 companies · $430 in 2025
The $430 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $521 · 2020: $185 · 2021: $405 · 2022: $456 · 2023: $188 · 2024: $155 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $773.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,066.07 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $276.29 | 2021-2025 | Lifevest |
| Edwards Lifesciences Corporation | $273.99 | 2019-2025 | Sapien 3 Ultra Resilia |
| Pfizer INC. | $139.61 | 2019-2025 | |
| Medtronic Vascular, INC. | $124.99 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $104.75 | 2020-2025 | Camzyos |
| Novo Nordisk INC | $64.29 | 2023 | |
| Lundbeck LLC | $60.87 | 2019 | |
| Novartis Pharmaceuticals Corporation | $55.93 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $45.53 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $25.82 | 2019-2022 | |
| Lantheus Medical Imaging, INC. | $24.87 | 2025 | |
| Merck Sharp & Dohme LLC | $21.70 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $16.86 | 2019 | |
| Amarin Pharma, INC. | $16.06 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $11.27 | 2019 | |
| Amgen INC. | $11.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunilkumar Rao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.